Here are relevant reports on : tissue-arrays-market
-
Tissue Dissection Market by Method (Blunt, Sharp, Diathermy), Technology (Ultrasound, Electrosurgery, Hydromechanical, Pneumodissection), Product (Scissors, Needles, Hammers, Laser, RF), Application (Surgical, Diagnostic, Forensic) - Forecasts to 2022
The global Tissue Dissection market is poised to witness sustainable growth during the forecast period. As the number of surgical & clinical procedures is increasing every year along with rising criminal cases (including murder, homicide, & rape) market demand for these instruments will continue to grow for related forensic applications, over next decade. Furthermore, the introduction of minimally invasive products for tissue dissection and increasing demand and adoption of these technologies in surgical procedures are expected to provide additional growth opportunities for the market growth.
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Stem Cell Therapy Market by Cell Source (Adipose Tissue, Bone Marrow, Placenta, Umbilical Cord, iPSC), Type (Autologus Stem Cell), Therapeutic Application (Musculoskeletal, Wounds, Surgeries, Cardiovascular, Neurological), End User - Global Forecast to 2035
The global stem cell therapy market is projected to reach USD 3.65 billion by 2035 from USD 0.48 billion in 2026, at a CAGR of 25.3% during the forecast period. Key players in the stem cell therapy market include Vericel Corporation (US), Mesoblast (Australia), MEDIPOST (South Korea), JCR Pharmaceuticals Co., Ltd. (Japan), Takeda Pharmaceutical Company Limited (Japan), Anterogen Co., Ltd. (South Korea), CorestemChemon Inc. / Corestem, Inc. (South Korea), Vertex Pharmaceuticals (US), Pharmicell Co., Ltd. (South Korea), Holostem Terapie Avanzate Srl (Italy), Stempeutics Research Pvt. Ltd. (India), Cipla Limited (India), Bayer AG (Germany), Aspen Neuroscience (US), Longeveron Inc. (US), and Smith+Nephew (UK).
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Synthetic Biology Market by Tools (Oligonucleotides, Enzymes, Synthetic Cells), Technology (Sequencing, Bioinformatics), Applications (Drug Discovery, Tissue Regeneration, Biofuel, Food, Agriculture, Consumer Care, Environmental) - Global Forecast to 2029
The global synthetic biology market, valued at US$11.97 billion in 2023, stood at US$12.33 billion in 2024 and is projected to advance at a resilient CAGR of 20.6% from 2024 to 2029, culminating in a forecasted valuation of US$31.52 billion by the end of the period. Some of the prominent factors driving the growth of the market include the rising demand for bio-based products, increased funding in R&D, and collaborations.
- Published: November 2024
- Price: $ 4950
- TOC Available:
-
Tissue Diagnostics Market by Product (Consumables [Antibodies, Kits, Reagents, Probes], Instruments [Systems, Scanner], Software, Services), Technology (ISH, IHC, Slide Staining), Disease Type (Breast Cancer, Lymphoma, Prostate Cancer) - Global Forecast to 2030
The global Tissue Diagnostics market, valued at USD 6.19 billion in 2024, stood at USD 6.74 billion in 2025 and is projected to advance at a resilient CAGR of 10.0% from 2025 to 2030, culminating in a forecasted valuation of USD10.86 billion by the end of the period. The market growth is driven by the rising incidence of cancer and the growing demand for digital pathology, which are fueling the need for more accurate and high-throughput tissue-based diagnostics.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Cardiac Tissue Engineering Market by Material (Scaffold, Stem cells), Product (Heart Valve, Vascular Grafts), Applications (MI,Congenital Heart Disease), End-User (Hospitals & Clinics, Academics & Research Institutes) - Global Forecast to 2029
The global cardiac tissue engineering market, valued at US$546.8 million in 2023, stood at US$621.2 million in 2024 and is projected to advance at a resilient CAGR of 16.5% from 2024 to 2029, culminating in a forecasted valuation of US$1,333.6 million by the end of the period. This growth is driven by increased demand for regenerative medicine, advancements in 3D bioprinting, and rising cardiovascular disease prevalence.
- Published: September 2024
- Price: $ 4950
- TOC Available:
-
3D Cell Culture Market by Product (Scaffolds [Hydrogels, Solid Scaffolds], Scaffold-free [Low Attachment Plates, Microfluidics, Bioprinted]), Application (Cancer, Stem Cell Research, Tissue Engineering), Trends, End User, Region - Global Forecast to 2030
The global 3D cell culture market, valued at US$1.18 billion in 2024, stood at US$1.29 billion in 2025 and is projected to advance at a resilient CAGR of 11.7% from 2024 to 2030, culminating in a forecasted valuation of US$2.26 billion by the end of the period. The market growth is driven by the adoption of personalized medicine globally for multiple diseases and government support & funding for 3D cell culture.
- Published: October 2025
- Price: $ 4950
- TOC Available:
-
Dental Soft-tissue Regeneration Market by Product Type (Autografts, Synthetic Biomaterials, Collagen-based Membranes), Application (Implantology, Periodontology), End User (Dental Hospitals, DSO's & Independent Clinics), Region - Global Forecast to 2030
The global dental soft-tissue regeneration market, valued at US$0.36 billion in 2024, stood at US$0.38 billion in 2025 and is projected to advance at a resilient CAGR of 6.8% from 2025 to 2030, culminating in a forecasted valuation of US$ 0.53 billion by the end of the period. The growth of this market can be attributed to the expansion of pharmaceutical manufacturing facilities, increased demand for advanced biomaterials, and the rapid growth of contract manufacturing companies.
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
Orthopedic Biomaterials Market by Type (Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials, Natural Biomaterials), Application (Joint Replacement, Spine Surgery, Bioresorbable Tissue Fixation, Orthobiologics, & Fracture Fixation) - Forecast to 2030
The orthopedic biomaterials market, valued at US$15.74 billion in 2024, stood at US$16.95 billion in 2025 and is projected to advance at a resilient CAGR of 8.0% from 2025 to 2030, culminating in a forecasted valuation of US$24.86 billion by the end of the period. This market encompasses load-bearing implants, bone cements, bioresorbable fixation devices, injectable viscoelastic gels, regenerative scaffolds, and specialized design-related services.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Prosthetic Heart Valve Market by Type (Transcatheter Heart Valve, Tissue Heart Valve, and Mechanical Heart Valve), and Region (North America, Europe, Asia-Pacific, and RoW) - Global Forecast to 2022
The prosthetic heart valves market is growing at a CAGR of 12.9%. Some of the prominent players in the market are Medtronic plc (Ireland), Edwards Lifesciences Corporation (U.S.), Boston Scientific Corporation (U.S.), St. Jude Medical, Inc. (an Abbott Laboratories Company) (U.S.), LivaNova PLC (U.K.), Symetis SA (Switzerland), Jenavalve Technology, Inc. (Germany), CryoLife, Inc. (U.S.), TTK Healthcare Limited (India), Colibri Heart Valve, LLC (U.S.), Lepu Medical Technology Co., Ltd. (China), and Braile Biomédica (Brazil) are the prominent players in the global prosthetic heart valves market.
- Published: June 2017
- Price: $ 4950
- TOC Available:
-
Cell Culture Equipment Market by Type (Supporting, Bioreactors, Storage), Application (Biopharma Production, Diagnostics, Tissue Engineering), End User (Pharma & Biotech Companies, Hospitals & Diagnostic Labs, Academia), Region - Global Forecast to 2031
The Cell Culture Equipment market, valued at USD 7.77 billion in 2025, stood at USD 8.36 billion in 2026 and is projected to advance at a resilient CAGR of 11.1% from 2026 to 2031, culminating in a forecasted valuation of USD 14.18 billion by the end of the period. Cell culture equipment encompasses the instruments used to grow and maintain cells in controlled laboratory environments for medical, research, and production purposes.
- Published: June 2026
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
